Collectively, these data highlight the multifaceted and beneficial effects of Se and selenoproteins in modulating both innate and adaptive immune responses in IBD and involving specific metabolic processes, which offer promising targets for therapeutic interventions (Figure 3). The gene discussed is SELENOS; the disease is irritable bowel syndrome.